Echocardiographic Assessment of Biventricular Function in 249 Patients During the Peri-Extracorporeal Membrane Oxygenation Period: Procedural and Ethical Questions

USE OF EXTRACORPOREAL membrane oxygenation (ECMO) has increased dramatically in recent years. The use of ECMO catapulted around 2009 because of the following 3 major events: the global pandemic of the H1N1 influenza, the publication of the CESAR trial, and ongoing improvements in ECMO circuitry with polymethylpentene oxygenators and cannulae specifically designed for ECMO.1 As discussed by Ortoleva et al. in this issue of the Journal of Cardiothoracic and Vascular Anesthesia, the Extracorporeal Life Support Organization reported more than 10,000 ECMO cases in 379 centers in 2017.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Tags: Editorial Source Type: research